Zhongzhi Pharmaceutical Holdings Limited

中 智 藥 業 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 3737)

ANNUAL GENERAL MEETING FOR THE YEAR ENDED 31 DECEMBER 2020

FORM OF PROXY

I/We1 of

being the registered holder(s) of2shares (the "Shares") of HK$0.01

each in the capital of Zhongzhi Pharmaceutical Holdings Limited (the "Company"), HEREBY APPOINT THE CHAIRMAN OF THE MEETING3, or

of

(who representsshares held by me/us)2 as my/our proxy

to attend and act for me/us and on my/our behalf at the annual general meeting (the "Meeting") of the Company to be held at Suite 2703, 27/F., Shui On Centre, 6-8 Harbour Road, Wanchai, Hong Kong on Tuesday, 18 May 2021 at 2:30 p.m. (or at any adjournment thereof) for the purpose of considering and, if thought fit, passing the resolutions as set out in the notice convening the Meeting and at the Meeting (or at any adjournment thereof) to vote for me/us and in my/our name(s) in respect of such resolutions as hereunder indicated, and, if no such indication is given, as my/our proxy thinks fit. My/our proxy will also be entitled to vote on any matter properly put to the Meeting in such manner as he/she thinks fit.

ORDINARY RESOLUTIONS

FOR4

AGAINST4

1.

To receive and approve the audited consolidated financial statements and the reports of the directors and

the auditor of the Company for the year ended 31 December 2020

2.

(a) to re-elect Mr. Lai Zhi Tian as an executive director of the Company

(b) to re-elect Mr. Lai Ying Feng as an executive director of the Company

(c) to re-elect Mr. Cheng Jin Le as an executive director of the Company

3.

To authorise the Board to fix the remuneration of all the directors of the Company for the year ending 31

December 2021

4.

To re-appoint Ernst & Young as the auditor of the Company and to authorise the Board to fix their

remuneration for the year ending 31 December 2021

5.

To grant a general mandate to the directors of the Company to repurchase shares of the Company not

exceeding 10% of the total number of issued shares of the Company

6.

To grant a general mandate to the directors of the Company to allot, issue and deal with additional shares

in the Company not exceeding 20% of the total number of issued shares of the Company

7.

To extend the general mandate granted to the directors of the Company to allot, issue and deal with shares

by the number of shares repurchased

Signature5

Date

Notes:

  1. Full name(s) and address(es) must be inserted in BLOCK CAPITALS. The names of all joint registered holders should be stated.
  2. Please insert the number of Shares registered in your name(s) to which this proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all Shares registered in your name(s).
  3. If any proxy other than the Chairman of the Meeting is preferred, strike out "THE CHAIRMAN OF THE MEETING, or" and insert the name and address of the proxy desired in the space provided. ANY
    ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON WHO SIGNS IT.
  4. IMPORTANT: If you wish to vote for a resolution, tick in the box marked "For". If you wish to vote against a resolution, tick in the box marked "Against".
    If no direction is given, your proxy may vote or abstain as he/she thinks fit. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the Meeting other than referred to the notice convening the Meeting.
  5. This form of proxy must be signed by you or your attorney duly authorized in writing or, in the case of a corporation, must be either under its common seal or under the hand of an officer, attorney or other person duly authorized to sign the same.
  6. In order to be valid, this form of proxy together with the notarially certified power of attorney (if any) or other authority (if any) under which it is signed or a notarially certified copy thereof, must be lodged with the branch share registrar and transfer office of the Company in Hong Kong, Union Registrars Limited, at Suites 3301-04, 33/F., Two Chinachem Exchange Square, 338 King's Road, North Point, Hong Kong not less than 48 hours (i.e. 2:30 p.m. on Sunday, 16 May 2021) before the time appointed for holding of the Meeting or the adjourned Meeting.
  7. In the case of joint holders of shares, any one of such holders may vote at the Meeting, either personally or by proxy, in respect of such shares as if he were solely entitled thereto, but if more than one of such joint holders are present at the Meeting personally or by proxy, that one of the said persons so present whose name stands first in the register of members of the Company in respect of such shares shall alone be entitled to vote in respect thereof.
  8. The proxy need not be a member of the Company but must attend the Meeting in person to represent you.
  9. Completion and return of this form will not preclude you from attending and voting in person at the Meeting if you so wish. If you attend and vote at the Meeting, the authority of your proxy will be revoked.
  10. The full text of the proposed resolutions appears in the notice of the Meeting.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy's (or proxies') name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the Meeting of the Company (the 'Purposes'). We may transfer your and your proxy's (or proxies') name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorized by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy's (or proxies') name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/ or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to the Company/Union Registrars Limited at the above address.

Attachments

  • Original document
  • Permalink

Disclaimer

Zhongzhi Pharmaceutical Holdings Ltd. published this content on 14 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 April 2021 09:42:01 UTC.